Charles River Laboratories Inte P/E Ratio 2008–2025
Charles River Laboratories Inte reported 923.00 of price-to-earnings ratio for fiscal 2024. That was 3499.9% higher than fiscal 2023. Compared with fiscal 2019, the change was +2963.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | — | — |
| FY 2024 | 923.00 | +3499.9% |
| FY 2023 | 25.64 | +11.5% |
| FY 2022 | 22.99 | -53.6% |
| FY 2021 | 49.58 | +42.9% |
| FY 2020 | 34.70 | +15.2% |
| FY 2019 | 30.13 | +23.0% |
| FY 2018 | 24.50 | -43.1% |
| FY 2017 | 43.09 | +82.7% |
| FY 2016 | 23.59 | -8.2% |
| FY 2015 | 25.68 | +7.4% |
| FY 2014 | 23.92 | -4.4% |
| FY 2013 | 25.02 | +34.2% |
| FY 2012 | 18.64 | +46.0% |
| FY 2011 | 12.77 | — |
| FY 2010 | — | — |
| FY 2009 | 19.36 | — |
| FY 2008 | — | — |
Source: Charles River Laboratories Inte SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CRL 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Charles River Laboratories Inte reported 923.00 of price-to-earnings ratio for fiscal 2024. That was 3499.9% higher than fiscal 2023. Compared with fiscal 2019, the change was +2963.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Charles River Laboratories Inte
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCharles River Laboratories Inte — frequently asked questions
What is Charles River Laboratories Inte's price-to-earnings ratio?
Charles River Laboratories Inte (CRL) reported price-to-earnings ratio of 923.00 for fiscal year 2024, per its SEC filings.
How has Charles River Laboratories Inte's price-to-earnings ratio changed over time?
Between fiscal 2008 and 2025, CRL's price-to-earnings ratio grew at roughly 25.5% per year (compound annual rate), from 19.36 to 923.00.
Where does this data come from?
Figures are computed from Charles River Laboratories Inte's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More CRL financial history
Full CRL fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →